Global Softgel Capsules

Softgel Capsules Comprehensive Study by Type (Gelatin type, Non-animal type (Starches, Pullulan, Others)), Application (Prescription Medicine, Health Dietary Supplyments), End User (Pharmaceutical, Health Supplements, Others) Players and Region - Global Market Outlook to 2030

Softgel Capsules Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Softgel Capsules
A softgel capsules are the gelatin-based shell surrounding a liquid fill. Softgel shells are a combination of gelatin, water, opacifier and a plasticizer such as glycerin or sorbitol. Increasing healthcare awareness across people and rising intake of pharmaceutical drugs are the main factors who are driving the market of capsules. A rise in applications of softgel capsules in nutraceutical industries is the main opportunity to the entry in this market.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Softgel Capsules market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Catalent (United States), Aenova (Germany), NBTY (United States), Procaps (United States), Patheon (United States), EuroCaps (United Kingdom), Captek (United States), Strides Arcolab (India), Capsugel (United States), Soft Gel Technologies (United States) and Roquette (France) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Amway (United States), Sirio Pharma (China), Baihe Biotech (China), Shineway (China) and Guangdong Yichao (China).

Segmentation Overview
AMA Research has segmented the market of Global Softgel Capsules market by Type (Gelatin type and Non-animal type [Starches, Pullulan, Others]), Application (Prescription Medicine and Health Dietary Supplyments) and Region.



On the basis of geography, the market of Softgel Capsules has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End User, the sub-segment i.e. Pharmaceutical will boost the Softgel Capsules market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increasing Awareness for Healthcare across People and Rising Intake of Pharmaceutical Drug

Market Growth Drivers:
Growth in the Pharmaceutical Industry and Increasing Healthcare Expenditure in Emerging Countries

Challenges:
fluctuation in the Prices of Raw Materials

Restraints:
High Cost Associated with the Capsules

Opportunities:
Increased consumption of Capsuled vitamin and Nutrition, Rising Applications of Softgel Capsules in Nutraceutical Industries and Technological Advancements in Softgel Capsules

Market Leaders and their expansionary development strategies
In August 2021, Catalent, Inc., the leading global provider of development sciences and manufacturing platforms for medicines, including biotherapeutics; cell and gene therapies; and consumer health products, today announced that it has reached an agreement to acquire Bettera Holdings, LLC, a major manufacturer in the high-growth gummy, soft chew, and lozenge segments of the nutritional supplements market
In November 2020, Roquette, a French plant-based ingredients company and pharmaceutical excipients provider, announced the launch of its pea starch technology, Lycagel, for vegetarian softgel capsule formulations.


Key Target Audience
Soft gel capsules manufacturers, Soft gel capsules suppliers, Medical research laboratories, Research Institutes, Research and Development (R&D) Companies, Market Research and Consulting Service Providers and Potential Investors

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Gelatin type
  • Non-animal type [Starches, Pullulan, Others]
By Application
  • Prescription Medicine
  • Health Dietary Supplyments
By End User
  • Pharmaceutical
  • Health Supplements
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growth in the Pharmaceutical Industry
      • 3.2.2. Increasing Healthcare Expenditure in Emerging Countries
    • 3.3. Market Challenges
      • 3.3.1. Fluctuation in the Prices of Raw Materials
    • 3.4. Market Trends
      • 3.4.1. Increasing Awareness for Healthcare across People
      • 3.4.2. Rising Intake of Pharmaceutical Drug
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Softgel Capsules, by Type, Application, End User and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Softgel Capsules (Value)
      • 5.2.1. Global Softgel Capsules by: Type (Value)
        • 5.2.1.1. Gelatin type
        • 5.2.1.2. Non-animal type [Starches, Pullulan, Others]
      • 5.2.2. Global Softgel Capsules by: Application (Value)
        • 5.2.2.1. Prescription Medicine
        • 5.2.2.2. Health Dietary Supplyments
      • 5.2.3. Global Softgel Capsules by: End User (Value)
        • 5.2.3.1. Pharmaceutical
        • 5.2.3.2. Health Supplements
        • 5.2.3.3. Others
      • 5.2.4. Global Softgel Capsules Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Softgel Capsules (Volume)
      • 5.3.1. Global Softgel Capsules by: Type (Volume)
        • 5.3.1.1. Gelatin type
        • 5.3.1.2. Non-animal type [Starches, Pullulan, Others]
      • 5.3.2. Global Softgel Capsules by: Application (Volume)
        • 5.3.2.1. Prescription Medicine
        • 5.3.2.2. Health Dietary Supplyments
      • 5.3.3. Global Softgel Capsules by: End User (Volume)
        • 5.3.3.1. Pharmaceutical
        • 5.3.3.2. Health Supplements
        • 5.3.3.3. Others
      • 5.3.4. Global Softgel Capsules Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Softgel Capsules (Price)
      • 5.4.1. Global Softgel Capsules by: Type (Price)
  • 6. Softgel Capsules: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Catalent (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Aenova (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. NBTY (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Procaps (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Patheon (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. EuroCaps (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Captek (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Strides Arcolab (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Capsugel (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Soft Gel Technologies (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Roquette (France)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Softgel Capsules Sale, by Type, Application, End User and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Softgel Capsules (Value)
      • 7.2.1. Global Softgel Capsules by: Type (Value)
        • 7.2.1.1. Gelatin type
        • 7.2.1.2. Non-animal type [Starches, Pullulan, Others]
      • 7.2.2. Global Softgel Capsules by: Application (Value)
        • 7.2.2.1. Prescription Medicine
        • 7.2.2.2. Health Dietary Supplyments
      • 7.2.3. Global Softgel Capsules by: End User (Value)
        • 7.2.3.1. Pharmaceutical
        • 7.2.3.2. Health Supplements
        • 7.2.3.3. Others
      • 7.2.4. Global Softgel Capsules Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Softgel Capsules (Volume)
      • 7.3.1. Global Softgel Capsules by: Type (Volume)
        • 7.3.1.1. Gelatin type
        • 7.3.1.2. Non-animal type [Starches, Pullulan, Others]
      • 7.3.2. Global Softgel Capsules by: Application (Volume)
        • 7.3.2.1. Prescription Medicine
        • 7.3.2.2. Health Dietary Supplyments
      • 7.3.3. Global Softgel Capsules by: End User (Volume)
        • 7.3.3.1. Pharmaceutical
        • 7.3.3.2. Health Supplements
        • 7.3.3.3. Others
      • 7.3.4. Global Softgel Capsules Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Softgel Capsules (Price)
      • 7.4.1. Global Softgel Capsules by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Softgel Capsules: by Type(USD Million)
  • Table 2. Softgel Capsules Gelatin type , by Region USD Million (2018-2023)
  • Table 3. Softgel Capsules Non-animal type [Starches, Pullulan, Others] , by Region USD Million (2018-2023)
  • Table 4. Softgel Capsules: by Application(USD Million)
  • Table 5. Softgel Capsules Prescription Medicine , by Region USD Million (2018-2023)
  • Table 6. Softgel Capsules Health Dietary Supplyments , by Region USD Million (2018-2023)
  • Table 7. Softgel Capsules: by End User(USD Million)
  • Table 8. Softgel Capsules Pharmaceutical , by Region USD Million (2018-2023)
  • Table 9. Softgel Capsules Health Supplements , by Region USD Million (2018-2023)
  • Table 10. Softgel Capsules Others , by Region USD Million (2018-2023)
  • Table 11. South America Softgel Capsules, by Country USD Million (2018-2023)
  • Table 12. South America Softgel Capsules, by Type USD Million (2018-2023)
  • Table 13. South America Softgel Capsules, by Application USD Million (2018-2023)
  • Table 14. South America Softgel Capsules, by End User USD Million (2018-2023)
  • Table 15. Brazil Softgel Capsules, by Type USD Million (2018-2023)
  • Table 16. Brazil Softgel Capsules, by Application USD Million (2018-2023)
  • Table 17. Brazil Softgel Capsules, by End User USD Million (2018-2023)
  • Table 18. Argentina Softgel Capsules, by Type USD Million (2018-2023)
  • Table 19. Argentina Softgel Capsules, by Application USD Million (2018-2023)
  • Table 20. Argentina Softgel Capsules, by End User USD Million (2018-2023)
  • Table 21. Rest of South America Softgel Capsules, by Type USD Million (2018-2023)
  • Table 22. Rest of South America Softgel Capsules, by Application USD Million (2018-2023)
  • Table 23. Rest of South America Softgel Capsules, by End User USD Million (2018-2023)
  • Table 24. Asia Pacific Softgel Capsules, by Country USD Million (2018-2023)
  • Table 25. Asia Pacific Softgel Capsules, by Type USD Million (2018-2023)
  • Table 26. Asia Pacific Softgel Capsules, by Application USD Million (2018-2023)
  • Table 27. Asia Pacific Softgel Capsules, by End User USD Million (2018-2023)
  • Table 28. China Softgel Capsules, by Type USD Million (2018-2023)
  • Table 29. China Softgel Capsules, by Application USD Million (2018-2023)
  • Table 30. China Softgel Capsules, by End User USD Million (2018-2023)
  • Table 31. Japan Softgel Capsules, by Type USD Million (2018-2023)
  • Table 32. Japan Softgel Capsules, by Application USD Million (2018-2023)
  • Table 33. Japan Softgel Capsules, by End User USD Million (2018-2023)
  • Table 34. India Softgel Capsules, by Type USD Million (2018-2023)
  • Table 35. India Softgel Capsules, by Application USD Million (2018-2023)
  • Table 36. India Softgel Capsules, by End User USD Million (2018-2023)
  • Table 37. South Korea Softgel Capsules, by Type USD Million (2018-2023)
  • Table 38. South Korea Softgel Capsules, by Application USD Million (2018-2023)
  • Table 39. South Korea Softgel Capsules, by End User USD Million (2018-2023)
  • Table 40. Taiwan Softgel Capsules, by Type USD Million (2018-2023)
  • Table 41. Taiwan Softgel Capsules, by Application USD Million (2018-2023)
  • Table 42. Taiwan Softgel Capsules, by End User USD Million (2018-2023)
  • Table 43. Australia Softgel Capsules, by Type USD Million (2018-2023)
  • Table 44. Australia Softgel Capsules, by Application USD Million (2018-2023)
  • Table 45. Australia Softgel Capsules, by End User USD Million (2018-2023)
  • Table 46. Rest of Asia-Pacific Softgel Capsules, by Type USD Million (2018-2023)
  • Table 47. Rest of Asia-Pacific Softgel Capsules, by Application USD Million (2018-2023)
  • Table 48. Rest of Asia-Pacific Softgel Capsules, by End User USD Million (2018-2023)
  • Table 49. Europe Softgel Capsules, by Country USD Million (2018-2023)
  • Table 50. Europe Softgel Capsules, by Type USD Million (2018-2023)
  • Table 51. Europe Softgel Capsules, by Application USD Million (2018-2023)
  • Table 52. Europe Softgel Capsules, by End User USD Million (2018-2023)
  • Table 53. Germany Softgel Capsules, by Type USD Million (2018-2023)
  • Table 54. Germany Softgel Capsules, by Application USD Million (2018-2023)
  • Table 55. Germany Softgel Capsules, by End User USD Million (2018-2023)
  • Table 56. France Softgel Capsules, by Type USD Million (2018-2023)
  • Table 57. France Softgel Capsules, by Application USD Million (2018-2023)
  • Table 58. France Softgel Capsules, by End User USD Million (2018-2023)
  • Table 59. Italy Softgel Capsules, by Type USD Million (2018-2023)
  • Table 60. Italy Softgel Capsules, by Application USD Million (2018-2023)
  • Table 61. Italy Softgel Capsules, by End User USD Million (2018-2023)
  • Table 62. United Kingdom Softgel Capsules, by Type USD Million (2018-2023)
  • Table 63. United Kingdom Softgel Capsules, by Application USD Million (2018-2023)
  • Table 64. United Kingdom Softgel Capsules, by End User USD Million (2018-2023)
  • Table 65. Netherlands Softgel Capsules, by Type USD Million (2018-2023)
  • Table 66. Netherlands Softgel Capsules, by Application USD Million (2018-2023)
  • Table 67. Netherlands Softgel Capsules, by End User USD Million (2018-2023)
  • Table 68. Rest of Europe Softgel Capsules, by Type USD Million (2018-2023)
  • Table 69. Rest of Europe Softgel Capsules, by Application USD Million (2018-2023)
  • Table 70. Rest of Europe Softgel Capsules, by End User USD Million (2018-2023)
  • Table 71. MEA Softgel Capsules, by Country USD Million (2018-2023)
  • Table 72. MEA Softgel Capsules, by Type USD Million (2018-2023)
  • Table 73. MEA Softgel Capsules, by Application USD Million (2018-2023)
  • Table 74. MEA Softgel Capsules, by End User USD Million (2018-2023)
  • Table 75. Middle East Softgel Capsules, by Type USD Million (2018-2023)
  • Table 76. Middle East Softgel Capsules, by Application USD Million (2018-2023)
  • Table 77. Middle East Softgel Capsules, by End User USD Million (2018-2023)
  • Table 78. Africa Softgel Capsules, by Type USD Million (2018-2023)
  • Table 79. Africa Softgel Capsules, by Application USD Million (2018-2023)
  • Table 80. Africa Softgel Capsules, by End User USD Million (2018-2023)
  • Table 81. North America Softgel Capsules, by Country USD Million (2018-2023)
  • Table 82. North America Softgel Capsules, by Type USD Million (2018-2023)
  • Table 83. North America Softgel Capsules, by Application USD Million (2018-2023)
  • Table 84. North America Softgel Capsules, by End User USD Million (2018-2023)
  • Table 85. United States Softgel Capsules, by Type USD Million (2018-2023)
  • Table 86. United States Softgel Capsules, by Application USD Million (2018-2023)
  • Table 87. United States Softgel Capsules, by End User USD Million (2018-2023)
  • Table 88. Canada Softgel Capsules, by Type USD Million (2018-2023)
  • Table 89. Canada Softgel Capsules, by Application USD Million (2018-2023)
  • Table 90. Canada Softgel Capsules, by End User USD Million (2018-2023)
  • Table 91. Mexico Softgel Capsules, by Type USD Million (2018-2023)
  • Table 92. Mexico Softgel Capsules, by Application USD Million (2018-2023)
  • Table 93. Mexico Softgel Capsules, by End User USD Million (2018-2023)
  • Table 94. Softgel Capsules Sales: by Type(Unit)
  • Table 95. Softgel Capsules Sales Gelatin type , by Region Unit (2018-2023)
  • Table 96. Softgel Capsules Sales Non-animal type [Starches, Pullulan, Others] , by Region Unit (2018-2023)
  • Table 97. Softgel Capsules Sales: by Application(Unit)
  • Table 98. Softgel Capsules Sales Prescription Medicine , by Region Unit (2018-2023)
  • Table 99. Softgel Capsules Sales Health Dietary Supplyments , by Region Unit (2018-2023)
  • Table 100. Softgel Capsules Sales: by End User(Unit)
  • Table 101. Softgel Capsules Sales Pharmaceutical , by Region Unit (2018-2023)
  • Table 102. Softgel Capsules Sales Health Supplements , by Region Unit (2018-2023)
  • Table 103. Softgel Capsules Sales Others , by Region Unit (2018-2023)
  • Table 104. South America Softgel Capsules Sales, by Country Unit (2018-2023)
  • Table 105. South America Softgel Capsules Sales, by Type Unit (2018-2023)
  • Table 106. South America Softgel Capsules Sales, by Application Unit (2018-2023)
  • Table 107. South America Softgel Capsules Sales, by End User Unit (2018-2023)
  • Table 108. Brazil Softgel Capsules Sales, by Type Unit (2018-2023)
  • Table 109. Brazil Softgel Capsules Sales, by Application Unit (2018-2023)
  • Table 110. Brazil Softgel Capsules Sales, by End User Unit (2018-2023)
  • Table 111. Argentina Softgel Capsules Sales, by Type Unit (2018-2023)
  • Table 112. Argentina Softgel Capsules Sales, by Application Unit (2018-2023)
  • Table 113. Argentina Softgel Capsules Sales, by End User Unit (2018-2023)
  • Table 114. Rest of South America Softgel Capsules Sales, by Type Unit (2018-2023)
  • Table 115. Rest of South America Softgel Capsules Sales, by Application Unit (2018-2023)
  • Table 116. Rest of South America Softgel Capsules Sales, by End User Unit (2018-2023)
  • Table 117. Asia Pacific Softgel Capsules Sales, by Country Unit (2018-2023)
  • Table 118. Asia Pacific Softgel Capsules Sales, by Type Unit (2018-2023)
  • Table 119. Asia Pacific Softgel Capsules Sales, by Application Unit (2018-2023)
  • Table 120. Asia Pacific Softgel Capsules Sales, by End User Unit (2018-2023)
  • Table 121. China Softgel Capsules Sales, by Type Unit (2018-2023)
  • Table 122. China Softgel Capsules Sales, by Application Unit (2018-2023)
  • Table 123. China Softgel Capsules Sales, by End User Unit (2018-2023)
  • Table 124. Japan Softgel Capsules Sales, by Type Unit (2018-2023)
  • Table 125. Japan Softgel Capsules Sales, by Application Unit (2018-2023)
  • Table 126. Japan Softgel Capsules Sales, by End User Unit (2018-2023)
  • Table 127. India Softgel Capsules Sales, by Type Unit (2018-2023)
  • Table 128. India Softgel Capsules Sales, by Application Unit (2018-2023)
  • Table 129. India Softgel Capsules Sales, by End User Unit (2018-2023)
  • Table 130. South Korea Softgel Capsules Sales, by Type Unit (2018-2023)
  • Table 131. South Korea Softgel Capsules Sales, by Application Unit (2018-2023)
  • Table 132. South Korea Softgel Capsules Sales, by End User Unit (2018-2023)
  • Table 133. Taiwan Softgel Capsules Sales, by Type Unit (2018-2023)
  • Table 134. Taiwan Softgel Capsules Sales, by Application Unit (2018-2023)
  • Table 135. Taiwan Softgel Capsules Sales, by End User Unit (2018-2023)
  • Table 136. Australia Softgel Capsules Sales, by Type Unit (2018-2023)
  • Table 137. Australia Softgel Capsules Sales, by Application Unit (2018-2023)
  • Table 138. Australia Softgel Capsules Sales, by End User Unit (2018-2023)
  • Table 139. Rest of Asia-Pacific Softgel Capsules Sales, by Type Unit (2018-2023)
  • Table 140. Rest of Asia-Pacific Softgel Capsules Sales, by Application Unit (2018-2023)
  • Table 141. Rest of Asia-Pacific Softgel Capsules Sales, by End User Unit (2018-2023)
  • Table 142. Europe Softgel Capsules Sales, by Country Unit (2018-2023)
  • Table 143. Europe Softgel Capsules Sales, by Type Unit (2018-2023)
  • Table 144. Europe Softgel Capsules Sales, by Application Unit (2018-2023)
  • Table 145. Europe Softgel Capsules Sales, by End User Unit (2018-2023)
  • Table 146. Germany Softgel Capsules Sales, by Type Unit (2018-2023)
  • Table 147. Germany Softgel Capsules Sales, by Application Unit (2018-2023)
  • Table 148. Germany Softgel Capsules Sales, by End User Unit (2018-2023)
  • Table 149. France Softgel Capsules Sales, by Type Unit (2018-2023)
  • Table 150. France Softgel Capsules Sales, by Application Unit (2018-2023)
  • Table 151. France Softgel Capsules Sales, by End User Unit (2018-2023)
  • Table 152. Italy Softgel Capsules Sales, by Type Unit (2018-2023)
  • Table 153. Italy Softgel Capsules Sales, by Application Unit (2018-2023)
  • Table 154. Italy Softgel Capsules Sales, by End User Unit (2018-2023)
  • Table 155. United Kingdom Softgel Capsules Sales, by Type Unit (2018-2023)
  • Table 156. United Kingdom Softgel Capsules Sales, by Application Unit (2018-2023)
  • Table 157. United Kingdom Softgel Capsules Sales, by End User Unit (2018-2023)
  • Table 158. Netherlands Softgel Capsules Sales, by Type Unit (2018-2023)
  • Table 159. Netherlands Softgel Capsules Sales, by Application Unit (2018-2023)
  • Table 160. Netherlands Softgel Capsules Sales, by End User Unit (2018-2023)
  • Table 161. Rest of Europe Softgel Capsules Sales, by Type Unit (2018-2023)
  • Table 162. Rest of Europe Softgel Capsules Sales, by Application Unit (2018-2023)
  • Table 163. Rest of Europe Softgel Capsules Sales, by End User Unit (2018-2023)
  • Table 164. MEA Softgel Capsules Sales, by Country Unit (2018-2023)
  • Table 165. MEA Softgel Capsules Sales, by Type Unit (2018-2023)
  • Table 166. MEA Softgel Capsules Sales, by Application Unit (2018-2023)
  • Table 167. MEA Softgel Capsules Sales, by End User Unit (2018-2023)
  • Table 168. Middle East Softgel Capsules Sales, by Type Unit (2018-2023)
  • Table 169. Middle East Softgel Capsules Sales, by Application Unit (2018-2023)
  • Table 170. Middle East Softgel Capsules Sales, by End User Unit (2018-2023)
  • Table 171. Africa Softgel Capsules Sales, by Type Unit (2018-2023)
  • Table 172. Africa Softgel Capsules Sales, by Application Unit (2018-2023)
  • Table 173. Africa Softgel Capsules Sales, by End User Unit (2018-2023)
  • Table 174. North America Softgel Capsules Sales, by Country Unit (2018-2023)
  • Table 175. North America Softgel Capsules Sales, by Type Unit (2018-2023)
  • Table 176. North America Softgel Capsules Sales, by Application Unit (2018-2023)
  • Table 177. North America Softgel Capsules Sales, by End User Unit (2018-2023)
  • Table 178. United States Softgel Capsules Sales, by Type Unit (2018-2023)
  • Table 179. United States Softgel Capsules Sales, by Application Unit (2018-2023)
  • Table 180. United States Softgel Capsules Sales, by End User Unit (2018-2023)
  • Table 181. Canada Softgel Capsules Sales, by Type Unit (2018-2023)
  • Table 182. Canada Softgel Capsules Sales, by Application Unit (2018-2023)
  • Table 183. Canada Softgel Capsules Sales, by End User Unit (2018-2023)
  • Table 184. Mexico Softgel Capsules Sales, by Type Unit (2018-2023)
  • Table 185. Mexico Softgel Capsules Sales, by Application Unit (2018-2023)
  • Table 186. Mexico Softgel Capsules Sales, by End User Unit (2018-2023)
  • Table 187. Softgel Capsules: by Type(USD/Units)
  • Table 188. Company Basic Information, Sales Area and Its Competitors
  • Table 189. Company Basic Information, Sales Area and Its Competitors
  • Table 190. Company Basic Information, Sales Area and Its Competitors
  • Table 191. Company Basic Information, Sales Area and Its Competitors
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Softgel Capsules: by Type(USD Million)
  • Table 200. Softgel Capsules Gelatin type , by Region USD Million (2025-2030)
  • Table 201. Softgel Capsules Non-animal type [Starches, Pullulan, Others] , by Region USD Million (2025-2030)
  • Table 202. Softgel Capsules: by Application(USD Million)
  • Table 203. Softgel Capsules Prescription Medicine , by Region USD Million (2025-2030)
  • Table 204. Softgel Capsules Health Dietary Supplyments , by Region USD Million (2025-2030)
  • Table 205. Softgel Capsules: by End User(USD Million)
  • Table 206. Softgel Capsules Pharmaceutical , by Region USD Million (2025-2030)
  • Table 207. Softgel Capsules Health Supplements , by Region USD Million (2025-2030)
  • Table 208. Softgel Capsules Others , by Region USD Million (2025-2030)
  • Table 209. South America Softgel Capsules, by Country USD Million (2025-2030)
  • Table 210. South America Softgel Capsules, by Type USD Million (2025-2030)
  • Table 211. South America Softgel Capsules, by Application USD Million (2025-2030)
  • Table 212. South America Softgel Capsules, by End User USD Million (2025-2030)
  • Table 213. Brazil Softgel Capsules, by Type USD Million (2025-2030)
  • Table 214. Brazil Softgel Capsules, by Application USD Million (2025-2030)
  • Table 215. Brazil Softgel Capsules, by End User USD Million (2025-2030)
  • Table 216. Argentina Softgel Capsules, by Type USD Million (2025-2030)
  • Table 217. Argentina Softgel Capsules, by Application USD Million (2025-2030)
  • Table 218. Argentina Softgel Capsules, by End User USD Million (2025-2030)
  • Table 219. Rest of South America Softgel Capsules, by Type USD Million (2025-2030)
  • Table 220. Rest of South America Softgel Capsules, by Application USD Million (2025-2030)
  • Table 221. Rest of South America Softgel Capsules, by End User USD Million (2025-2030)
  • Table 222. Asia Pacific Softgel Capsules, by Country USD Million (2025-2030)
  • Table 223. Asia Pacific Softgel Capsules, by Type USD Million (2025-2030)
  • Table 224. Asia Pacific Softgel Capsules, by Application USD Million (2025-2030)
  • Table 225. Asia Pacific Softgel Capsules, by End User USD Million (2025-2030)
  • Table 226. China Softgel Capsules, by Type USD Million (2025-2030)
  • Table 227. China Softgel Capsules, by Application USD Million (2025-2030)
  • Table 228. China Softgel Capsules, by End User USD Million (2025-2030)
  • Table 229. Japan Softgel Capsules, by Type USD Million (2025-2030)
  • Table 230. Japan Softgel Capsules, by Application USD Million (2025-2030)
  • Table 231. Japan Softgel Capsules, by End User USD Million (2025-2030)
  • Table 232. India Softgel Capsules, by Type USD Million (2025-2030)
  • Table 233. India Softgel Capsules, by Application USD Million (2025-2030)
  • Table 234. India Softgel Capsules, by End User USD Million (2025-2030)
  • Table 235. South Korea Softgel Capsules, by Type USD Million (2025-2030)
  • Table 236. South Korea Softgel Capsules, by Application USD Million (2025-2030)
  • Table 237. South Korea Softgel Capsules, by End User USD Million (2025-2030)
  • Table 238. Taiwan Softgel Capsules, by Type USD Million (2025-2030)
  • Table 239. Taiwan Softgel Capsules, by Application USD Million (2025-2030)
  • Table 240. Taiwan Softgel Capsules, by End User USD Million (2025-2030)
  • Table 241. Australia Softgel Capsules, by Type USD Million (2025-2030)
  • Table 242. Australia Softgel Capsules, by Application USD Million (2025-2030)
  • Table 243. Australia Softgel Capsules, by End User USD Million (2025-2030)
  • Table 244. Rest of Asia-Pacific Softgel Capsules, by Type USD Million (2025-2030)
  • Table 245. Rest of Asia-Pacific Softgel Capsules, by Application USD Million (2025-2030)
  • Table 246. Rest of Asia-Pacific Softgel Capsules, by End User USD Million (2025-2030)
  • Table 247. Europe Softgel Capsules, by Country USD Million (2025-2030)
  • Table 248. Europe Softgel Capsules, by Type USD Million (2025-2030)
  • Table 249. Europe Softgel Capsules, by Application USD Million (2025-2030)
  • Table 250. Europe Softgel Capsules, by End User USD Million (2025-2030)
  • Table 251. Germany Softgel Capsules, by Type USD Million (2025-2030)
  • Table 252. Germany Softgel Capsules, by Application USD Million (2025-2030)
  • Table 253. Germany Softgel Capsules, by End User USD Million (2025-2030)
  • Table 254. France Softgel Capsules, by Type USD Million (2025-2030)
  • Table 255. France Softgel Capsules, by Application USD Million (2025-2030)
  • Table 256. France Softgel Capsules, by End User USD Million (2025-2030)
  • Table 257. Italy Softgel Capsules, by Type USD Million (2025-2030)
  • Table 258. Italy Softgel Capsules, by Application USD Million (2025-2030)
  • Table 259. Italy Softgel Capsules, by End User USD Million (2025-2030)
  • Table 260. United Kingdom Softgel Capsules, by Type USD Million (2025-2030)
  • Table 261. United Kingdom Softgel Capsules, by Application USD Million (2025-2030)
  • Table 262. United Kingdom Softgel Capsules, by End User USD Million (2025-2030)
  • Table 263. Netherlands Softgel Capsules, by Type USD Million (2025-2030)
  • Table 264. Netherlands Softgel Capsules, by Application USD Million (2025-2030)
  • Table 265. Netherlands Softgel Capsules, by End User USD Million (2025-2030)
  • Table 266. Rest of Europe Softgel Capsules, by Type USD Million (2025-2030)
  • Table 267. Rest of Europe Softgel Capsules, by Application USD Million (2025-2030)
  • Table 268. Rest of Europe Softgel Capsules, by End User USD Million (2025-2030)
  • Table 269. MEA Softgel Capsules, by Country USD Million (2025-2030)
  • Table 270. MEA Softgel Capsules, by Type USD Million (2025-2030)
  • Table 271. MEA Softgel Capsules, by Application USD Million (2025-2030)
  • Table 272. MEA Softgel Capsules, by End User USD Million (2025-2030)
  • Table 273. Middle East Softgel Capsules, by Type USD Million (2025-2030)
  • Table 274. Middle East Softgel Capsules, by Application USD Million (2025-2030)
  • Table 275. Middle East Softgel Capsules, by End User USD Million (2025-2030)
  • Table 276. Africa Softgel Capsules, by Type USD Million (2025-2030)
  • Table 277. Africa Softgel Capsules, by Application USD Million (2025-2030)
  • Table 278. Africa Softgel Capsules, by End User USD Million (2025-2030)
  • Table 279. North America Softgel Capsules, by Country USD Million (2025-2030)
  • Table 280. North America Softgel Capsules, by Type USD Million (2025-2030)
  • Table 281. North America Softgel Capsules, by Application USD Million (2025-2030)
  • Table 282. North America Softgel Capsules, by End User USD Million (2025-2030)
  • Table 283. United States Softgel Capsules, by Type USD Million (2025-2030)
  • Table 284. United States Softgel Capsules, by Application USD Million (2025-2030)
  • Table 285. United States Softgel Capsules, by End User USD Million (2025-2030)
  • Table 286. Canada Softgel Capsules, by Type USD Million (2025-2030)
  • Table 287. Canada Softgel Capsules, by Application USD Million (2025-2030)
  • Table 288. Canada Softgel Capsules, by End User USD Million (2025-2030)
  • Table 289. Mexico Softgel Capsules, by Type USD Million (2025-2030)
  • Table 290. Mexico Softgel Capsules, by Application USD Million (2025-2030)
  • Table 291. Mexico Softgel Capsules, by End User USD Million (2025-2030)
  • Table 292. Softgel Capsules Sales: by Type(Unit)
  • Table 293. Softgel Capsules Sales Gelatin type , by Region Unit (2025-2030)
  • Table 294. Softgel Capsules Sales Non-animal type [Starches, Pullulan, Others] , by Region Unit (2025-2030)
  • Table 295. Softgel Capsules Sales: by Application(Unit)
  • Table 296. Softgel Capsules Sales Prescription Medicine , by Region Unit (2025-2030)
  • Table 297. Softgel Capsules Sales Health Dietary Supplyments , by Region Unit (2025-2030)
  • Table 298. Softgel Capsules Sales: by End User(Unit)
  • Table 299. Softgel Capsules Sales Pharmaceutical , by Region Unit (2025-2030)
  • Table 300. Softgel Capsules Sales Health Supplements , by Region Unit (2025-2030)
  • Table 301. Softgel Capsules Sales Others , by Region Unit (2025-2030)
  • Table 302. South America Softgel Capsules Sales, by Country Unit (2025-2030)
  • Table 303. South America Softgel Capsules Sales, by Type Unit (2025-2030)
  • Table 304. South America Softgel Capsules Sales, by Application Unit (2025-2030)
  • Table 305. South America Softgel Capsules Sales, by End User Unit (2025-2030)
  • Table 306. Brazil Softgel Capsules Sales, by Type Unit (2025-2030)
  • Table 307. Brazil Softgel Capsules Sales, by Application Unit (2025-2030)
  • Table 308. Brazil Softgel Capsules Sales, by End User Unit (2025-2030)
  • Table 309. Argentina Softgel Capsules Sales, by Type Unit (2025-2030)
  • Table 310. Argentina Softgel Capsules Sales, by Application Unit (2025-2030)
  • Table 311. Argentina Softgel Capsules Sales, by End User Unit (2025-2030)
  • Table 312. Rest of South America Softgel Capsules Sales, by Type Unit (2025-2030)
  • Table 313. Rest of South America Softgel Capsules Sales, by Application Unit (2025-2030)
  • Table 314. Rest of South America Softgel Capsules Sales, by End User Unit (2025-2030)
  • Table 315. Asia Pacific Softgel Capsules Sales, by Country Unit (2025-2030)
  • Table 316. Asia Pacific Softgel Capsules Sales, by Type Unit (2025-2030)
  • Table 317. Asia Pacific Softgel Capsules Sales, by Application Unit (2025-2030)
  • Table 318. Asia Pacific Softgel Capsules Sales, by End User Unit (2025-2030)
  • Table 319. China Softgel Capsules Sales, by Type Unit (2025-2030)
  • Table 320. China Softgel Capsules Sales, by Application Unit (2025-2030)
  • Table 321. China Softgel Capsules Sales, by End User Unit (2025-2030)
  • Table 322. Japan Softgel Capsules Sales, by Type Unit (2025-2030)
  • Table 323. Japan Softgel Capsules Sales, by Application Unit (2025-2030)
  • Table 324. Japan Softgel Capsules Sales, by End User Unit (2025-2030)
  • Table 325. India Softgel Capsules Sales, by Type Unit (2025-2030)
  • Table 326. India Softgel Capsules Sales, by Application Unit (2025-2030)
  • Table 327. India Softgel Capsules Sales, by End User Unit (2025-2030)
  • Table 328. South Korea Softgel Capsules Sales, by Type Unit (2025-2030)
  • Table 329. South Korea Softgel Capsules Sales, by Application Unit (2025-2030)
  • Table 330. South Korea Softgel Capsules Sales, by End User Unit (2025-2030)
  • Table 331. Taiwan Softgel Capsules Sales, by Type Unit (2025-2030)
  • Table 332. Taiwan Softgel Capsules Sales, by Application Unit (2025-2030)
  • Table 333. Taiwan Softgel Capsules Sales, by End User Unit (2025-2030)
  • Table 334. Australia Softgel Capsules Sales, by Type Unit (2025-2030)
  • Table 335. Australia Softgel Capsules Sales, by Application Unit (2025-2030)
  • Table 336. Australia Softgel Capsules Sales, by End User Unit (2025-2030)
  • Table 337. Rest of Asia-Pacific Softgel Capsules Sales, by Type Unit (2025-2030)
  • Table 338. Rest of Asia-Pacific Softgel Capsules Sales, by Application Unit (2025-2030)
  • Table 339. Rest of Asia-Pacific Softgel Capsules Sales, by End User Unit (2025-2030)
  • Table 340. Europe Softgel Capsules Sales, by Country Unit (2025-2030)
  • Table 341. Europe Softgel Capsules Sales, by Type Unit (2025-2030)
  • Table 342. Europe Softgel Capsules Sales, by Application Unit (2025-2030)
  • Table 343. Europe Softgel Capsules Sales, by End User Unit (2025-2030)
  • Table 344. Germany Softgel Capsules Sales, by Type Unit (2025-2030)
  • Table 345. Germany Softgel Capsules Sales, by Application Unit (2025-2030)
  • Table 346. Germany Softgel Capsules Sales, by End User Unit (2025-2030)
  • Table 347. France Softgel Capsules Sales, by Type Unit (2025-2030)
  • Table 348. France Softgel Capsules Sales, by Application Unit (2025-2030)
  • Table 349. France Softgel Capsules Sales, by End User Unit (2025-2030)
  • Table 350. Italy Softgel Capsules Sales, by Type Unit (2025-2030)
  • Table 351. Italy Softgel Capsules Sales, by Application Unit (2025-2030)
  • Table 352. Italy Softgel Capsules Sales, by End User Unit (2025-2030)
  • Table 353. United Kingdom Softgel Capsules Sales, by Type Unit (2025-2030)
  • Table 354. United Kingdom Softgel Capsules Sales, by Application Unit (2025-2030)
  • Table 355. United Kingdom Softgel Capsules Sales, by End User Unit (2025-2030)
  • Table 356. Netherlands Softgel Capsules Sales, by Type Unit (2025-2030)
  • Table 357. Netherlands Softgel Capsules Sales, by Application Unit (2025-2030)
  • Table 358. Netherlands Softgel Capsules Sales, by End User Unit (2025-2030)
  • Table 359. Rest of Europe Softgel Capsules Sales, by Type Unit (2025-2030)
  • Table 360. Rest of Europe Softgel Capsules Sales, by Application Unit (2025-2030)
  • Table 361. Rest of Europe Softgel Capsules Sales, by End User Unit (2025-2030)
  • Table 362. MEA Softgel Capsules Sales, by Country Unit (2025-2030)
  • Table 363. MEA Softgel Capsules Sales, by Type Unit (2025-2030)
  • Table 364. MEA Softgel Capsules Sales, by Application Unit (2025-2030)
  • Table 365. MEA Softgel Capsules Sales, by End User Unit (2025-2030)
  • Table 366. Middle East Softgel Capsules Sales, by Type Unit (2025-2030)
  • Table 367. Middle East Softgel Capsules Sales, by Application Unit (2025-2030)
  • Table 368. Middle East Softgel Capsules Sales, by End User Unit (2025-2030)
  • Table 369. Africa Softgel Capsules Sales, by Type Unit (2025-2030)
  • Table 370. Africa Softgel Capsules Sales, by Application Unit (2025-2030)
  • Table 371. Africa Softgel Capsules Sales, by End User Unit (2025-2030)
  • Table 372. North America Softgel Capsules Sales, by Country Unit (2025-2030)
  • Table 373. North America Softgel Capsules Sales, by Type Unit (2025-2030)
  • Table 374. North America Softgel Capsules Sales, by Application Unit (2025-2030)
  • Table 375. North America Softgel Capsules Sales, by End User Unit (2025-2030)
  • Table 376. United States Softgel Capsules Sales, by Type Unit (2025-2030)
  • Table 377. United States Softgel Capsules Sales, by Application Unit (2025-2030)
  • Table 378. United States Softgel Capsules Sales, by End User Unit (2025-2030)
  • Table 379. Canada Softgel Capsules Sales, by Type Unit (2025-2030)
  • Table 380. Canada Softgel Capsules Sales, by Application Unit (2025-2030)
  • Table 381. Canada Softgel Capsules Sales, by End User Unit (2025-2030)
  • Table 382. Mexico Softgel Capsules Sales, by Type Unit (2025-2030)
  • Table 383. Mexico Softgel Capsules Sales, by Application Unit (2025-2030)
  • Table 384. Mexico Softgel Capsules Sales, by End User Unit (2025-2030)
  • Table 385. Softgel Capsules: by Type(USD/Units)
  • Table 386. Research Programs/Design for This Report
  • Table 387. Key Data Information from Secondary Sources
  • Table 388. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Softgel Capsules: by Type USD Million (2018-2023)
  • Figure 5. Global Softgel Capsules: by Application USD Million (2018-2023)
  • Figure 6. Global Softgel Capsules: by End User USD Million (2018-2023)
  • Figure 7. South America Softgel Capsules Share (%), by Country
  • Figure 8. Asia Pacific Softgel Capsules Share (%), by Country
  • Figure 9. Europe Softgel Capsules Share (%), by Country
  • Figure 10. MEA Softgel Capsules Share (%), by Country
  • Figure 11. North America Softgel Capsules Share (%), by Country
  • Figure 12. Global Softgel Capsules: by Type Unit (2018-2023)
  • Figure 13. Global Softgel Capsules: by Application Unit (2018-2023)
  • Figure 14. Global Softgel Capsules: by End User Unit (2018-2023)
  • Figure 15. South America Softgel Capsules Share (%), by Country
  • Figure 16. Asia Pacific Softgel Capsules Share (%), by Country
  • Figure 17. Europe Softgel Capsules Share (%), by Country
  • Figure 18. MEA Softgel Capsules Share (%), by Country
  • Figure 19. North America Softgel Capsules Share (%), by Country
  • Figure 20. Global Softgel Capsules: by Type USD/Units (2018-2023)
  • Figure 21. Global Softgel Capsules share by Players 2023 (%)
  • Figure 22. Global Softgel Capsules share by Players (Top 3) 2023(%)
  • Figure 23. Global Softgel Capsules share by Players (Top 5) 2023(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Catalent (United States) Revenue, Net Income and Gross profit
  • Figure 26. Catalent (United States) Revenue: by Geography 2023
  • Figure 27. Aenova (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Aenova (Germany) Revenue: by Geography 2023
  • Figure 29. NBTY (United States) Revenue, Net Income and Gross profit
  • Figure 30. NBTY (United States) Revenue: by Geography 2023
  • Figure 31. Procaps (United States) Revenue, Net Income and Gross profit
  • Figure 32. Procaps (United States) Revenue: by Geography 2023
  • Figure 33. Patheon (United States) Revenue, Net Income and Gross profit
  • Figure 34. Patheon (United States) Revenue: by Geography 2023
  • Figure 35. EuroCaps (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 36. EuroCaps (United Kingdom) Revenue: by Geography 2023
  • Figure 37. Captek (United States) Revenue, Net Income and Gross profit
  • Figure 38. Captek (United States) Revenue: by Geography 2023
  • Figure 39. Strides Arcolab (India) Revenue, Net Income and Gross profit
  • Figure 40. Strides Arcolab (India) Revenue: by Geography 2023
  • Figure 41. Capsugel (United States) Revenue, Net Income and Gross profit
  • Figure 42. Capsugel (United States) Revenue: by Geography 2023
  • Figure 43. Soft Gel Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 44. Soft Gel Technologies (United States) Revenue: by Geography 2023
  • Figure 45. Roquette (France) Revenue, Net Income and Gross profit
  • Figure 46. Roquette (France) Revenue: by Geography 2023
  • Figure 47. Global Softgel Capsules: by Type USD Million (2025-2030)
  • Figure 48. Global Softgel Capsules: by Application USD Million (2025-2030)
  • Figure 49. Global Softgel Capsules: by End User USD Million (2025-2030)
  • Figure 50. South America Softgel Capsules Share (%), by Country
  • Figure 51. Asia Pacific Softgel Capsules Share (%), by Country
  • Figure 52. Europe Softgel Capsules Share (%), by Country
  • Figure 53. MEA Softgel Capsules Share (%), by Country
  • Figure 54. North America Softgel Capsules Share (%), by Country
  • Figure 55. Global Softgel Capsules: by Type Unit (2025-2030)
  • Figure 56. Global Softgel Capsules: by Application Unit (2025-2030)
  • Figure 57. Global Softgel Capsules: by End User Unit (2025-2030)
  • Figure 58. South America Softgel Capsules Share (%), by Country
  • Figure 59. Asia Pacific Softgel Capsules Share (%), by Country
  • Figure 60. Europe Softgel Capsules Share (%), by Country
  • Figure 61. MEA Softgel Capsules Share (%), by Country
  • Figure 62. North America Softgel Capsules Share (%), by Country
  • Figure 63. Global Softgel Capsules: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Catalent (United States)
  • Aenova (Germany)
  • NBTY (United States)
  • Procaps (United States)
  • Patheon (United States)
  • EuroCaps (United Kingdom)
  • Captek (United States)
  • Strides Arcolab (India)
  • Capsugel (United States)
  • Soft Gel Technologies (United States)
  • Roquette (France)
Additional players considered in the study are as follows:
Amway (United States) , Sirio Pharma (China) , Baihe Biotech (China) , Shineway (China) , Guangdong Yichao (China)
Select User Access Type

Key Highlights of Report


Mar 2024 169 Pages 55 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Softgel Capsules Quantitative research analysis
Global Softgel Capsules Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Catalent (United States), Aenova (Germany), NBTY (United States), Procaps (United States), Patheon (United States), EuroCaps (United Kingdom), Captek (United States), Strides Arcolab (India), Capsugel (United States), Soft Gel Technologies (United States) and Roquette (France) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing Awareness for Healthcare across People " is seen as one of major influencing trends for Softgel Capsules Market during projected period 2023-2030.
The Softgel Capsules market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Softgel Capsules Report?

Have a Query? Click Here

Other Related Reports

Healthcare Analytical Testing Services Comprehensive Study by Type (Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials, Microbial Testing), End User (Pharma...
$ 3350
Advanced Wound Care Comprehensive Study by Application (Acute Wounds, Chronic Wounds, Surgical Wounds, Others), End-Users (Hospitals, Clinic, Home, Others), Wound Therapy (Negative Pressure, Oxygen W...
$ 3650
Patchouli Oil Comprehensive Study by Type (Dark Patchouli Oil, Light Patchouli Oil), Application (Perfumery, Medicine, Flavorings, Others (Therapeutics, Pesticides, and Household)), Nature (Organic, ...
$ 3650
Malaria Vaccines Comprehensive Study by Type (Erythrocytic Vaccines, Combination Vaccines, Vectored Vaccines, Pre-Erythrocytic Vaccines, Others), Application (Hospitals, Specialty Clinics, Research I...
$ 3800
eHealth Comprehensive Study by Type (Electronic Health Records (EHR), Vendor Neutral Archive (VNA) and Picture Archiving & Communications Systems(PACS), Laboratory Information Systems (LIS), Teleheal...
$ 3800
Equine Healthcare Comprehensive Study by Type (Supplement Product, Therapeutic Product, Diagnostic Product), Application (Race Equine, Sport Equine), Therapeutic (Equine Therapeutics Market, Equine ...
$ 3750